Pscilly

Reviews of RE104 (luvesilocin) – 4-OH-DiPT prodrug

No reviews yet. Share the first one.

RE104 (luvesilocin) – 4-OH-DiPT prodrug by Reunion Neuroscience, Inc.

This investigational candidate is being studied in Phase 2 for postpartum depression; a Phase 3 trial was planned for 2026. Investigational; not for sale.

Guides about RE104 (luvesilocin) – 4-OH-DiPT prodrug

Related news